Deutsche Bank’s Crescent Biopharma CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-352
Closed -$106K 4681
2021
Q1
$106K Sell
352
-4
-1% -$1.43K ﹤0.01% 3952
2020
Q4
$133K Buy
356
+169
+90% +$59.2K ﹤0.01% 3693
2020
Q3
$58K Buy
187
+22
+13% +$8.41K ﹤0.01% 3811
2020
Q2
$62K Buy
165
+50
+43% +$14.2K ﹤0.01% 3706
2020
Q1
$26K Sell
115
-7
-6% -$2.68K ﹤0.01% 3837
2019
Q4
$63K Buy
122
+27
+28% +$14.6K ﹤0.01% 3844
2019
Q3
$40K Sell
95
-76
-44% -$48.9K ﹤0.01% 4048
2019
Q2
$201K Sell
171
-43
-20% -$51.4K ﹤0.01% 3822
2019
Q1
$265K Sell
214
-462
-68% -$529K ﹤0.01% 3836
2018
Q4
$639K Sell
676
-895
-57% -$1.08M ﹤0.01% 3177
2018
Q3
$2.26M Buy
1,571
+329
+26% +$498K ﹤0.01% 2776
2018
Q2
$2M Sell
1,242
-152
-11% -$261K ﹤0.01% 2949
2018
Q1
$2.26M Buy
1,394
+45
+3% +$93.6K ﹤0.01% 2781
2017
Q4
$2.26M Sell
1,349
-1,249
-48% -$1.65M ﹤0.01% 2636
2017
Q3
$3.63M Buy
2,598
+1,992
+329% +$2.34M ﹤0.01% 2114
2017
Q2
$676K Sell
606
-378
-38% -$312K ﹤0.01% 3275
2017
Q1
$533K Sell
984
-32
-3% -$19.6K ﹤0.01% 3046
2016
Q4
$618K Buy
1,016
+323
+47% +$202K ﹤0.01% 3039
2016
Q3
$495K Sell
693
-244
-26% -$187K ﹤0.01% 3194
2016
Q2
$679K Sell
937
-119
-11% -$82K ﹤0.01% 3111
2016
Q1
$629K Buy
1,056
+140
+15% +$71.8K ﹤0.01% 3085
2015
Q4
$523K Buy
916
+16
+2% +$10.6K ﹤0.01% 3254
2015
Q3
$503K Buy
900
+54
+6% +$39K ﹤0.01% 3356
2015
Q2
$672K Buy
846
+265
+46% +$219K ﹤0.01% 3220
2015
Q1
$483K Buy
581
+76
+15% +$59K ﹤0.01% 3316
2014
Q4
$363K Buy
505
+451
+835% +$353K ﹤0.01% 3897
2014
Q3
$37K Sell
54
-126
-70% -$102K ﹤0.01% 4991
2014
Q2
$151K Sell
180
-25
-12% -$24.9K ﹤0.01% 4312
2014
Q1
$334K Buy
+205
New +$248K ﹤0.01% 3575

Other funds holding CBIO